Vanguard files 13G/A showing 0 shares in SI-BONE (SIBN)
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
SI-BONE Inc amendment: The Vanguard Group filed Amendment No. 1 to a Schedule 13G/A reporting zero shares beneficially owned of SI-BONE Inc common stock, representing 0% of the class. The filing explains an internal realignment that caused certain Vanguard subsidiaries to report ownership separately in reliance on SEC Release No. 34-39538.
Positive
- None.
Negative
- None.
Insights
Amendment reflects reporting reallocation, not an economic stake change.
The filing states 0 shares beneficially owned and 0% of the class; it attributes the change to an internal realignment and disaggregation under SEC Release No. 34-39538.
Cash‑flow treatment and market activity are not disclosed; subsequent filings from the named Vanguard entities may show holdings if applicable.
FAQ
What did The Vanguard Group report for SI-BONE (SIBN)?
The Vanguard Group reported 0 shares beneficially owned, equal to 0% of SI-BONE Inc common stock. The filing attributes the reporting change to an internal realignment and disaggregation under SEC Release No. 34-39538.
Why did Vanguard report zero ownership in this 13G/A amendment?
The filing states that Vanguard reorganized and certain subsidiaries now report separately in reliance on SEC Release No. 34-39538. As a result, The Vanguard Group, Inc. no longer reports beneficial ownership for securities held by those subsidiaries.
Who signed the Schedule 13G/A amendment for SIBN?
The amendment was signed by Ashley Grim, Head of Global Fund Administration, on 03/27/2026. The signature attests to the reported ownership and the explanatory disclosure about the internal realignment.